FrancophonIA/ELRC3.0 huggingface dataset:
English: Inconsistent reduction in response to pertussis antigens as well as to inactivated polio vaccine (IPV) were observed.
Croatian: Primijećen je i nedosljedno smanjen odgovor na antigene pertusisa, kao i na inaktivirano cjepivo protiv poliomijelitisa (IPV).
English: Consequently, Prevenar should cover between 54 % and 84 % of isolates from invasive pneumococcal disease (IPD) in European children less than 2 years of age.
Croatian: Stoga bi Prevenar trebao pokriti 54% do 84% izolata invazivne pneumokokne bolesti u djece u Europi mlađe od 2 godine.
English: For the number of doses to be administered in the different age groups, see section 4.2.
Croatian: Broj doza koji se primjenjuje u različitih dobnih skupina vidjeti u dijelu 4.2.
English: Efficacy trials in the 2- to 5-year-old population have not been conducted.
Croatian: Nisu provedena ispitivanja učinkovitosti u populacije u dobi od 2 do 5 godina.
English: Infants aged 2 - 6 months:
Croatian: Dojenčad u dobi od 2 do 6 mjeseci:
English: There have been reports of overdose with Prevenar, including cases of administration of a higher than recommended dose and cases of subsequent doses administered closer than recommended to the previous dose.
Croatian: Zabilježeni su slučajevi predoziranja Prevenarom, uključujući slučajeve primjene viših doza od preporučenih i slučajeve kad je sljedeća doza bila primijenjena vremenski bliže prethodnoj dozi nego što je preporučeno.
English: Each 0.5 ml dose contains 2 micrograms of saccharide for serotypes 4, 9V, 14, 18C, 19F, and 23F, and 4 micrograms of serotype 6B per dose (16 micrograms total saccharide) conjugated to CRM197 carrier protein and adsorbed on aluminium phosphate (0.5 mg).
Croatian: Jedna doza od 0,5 ml sadrži 2 mikrograma saharida serotipova 4, 9V, 14, 18C, 19F i 23F i 4 mikrograma serotipa 6B po dozi (16 mikrograma ukupnih saharida) konjugiranih na proteinski nosač CRM197 i adsorbiranih na aluminijev fosfat (0,5 mg).
English: Sufficient data regarding interference on the concomitant administration of other hexavalent vaccines with Prevenar are currently not available.
Croatian: Trenutno nema dovoljno dostupnih podataka o interferenciji kod istovremene primjene drugih heksavalentnih cjepiva s Prevenarom.
English: In European children between 2 to 5 years of age, Prevenar should cover about 62 % to 83 % of the clinical isolates responsible for invasive pneumococcal disease.
Croatian: U Europi, u djece u dobi između 2 i 5 godina, Prevenar bi trebao pokriti oko 62% do 83% kliničkih izolata odgovornih za invazivnu pneumokoknu bolest.
English: SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF
Croatian: POSEBNE MJERE ZA UKLANJANJE NEISKORIŠTENOG LIJEKA ILI OTPADNIH MATERIJALA KOJI POTJEČU
English: Like all vaccines, Prevenar can cause side effects, although not everybody gets them.
Croatian: Kao i sva druga cjepiva, Prevenar može uzrokovati nuspojave, iako ih neće svi dobiti.
English: Efficacy against pneumonia
Croatian: Djelotvornost protiv upale pluća
English: No consistent increased local or systemic reactions within repeated doses were seen throughout the primary series or with the booster dose, the exceptions being a higher rate of transient tenderness (36.5 %) and tenderness that interfered with limb movement (18.5 %) were seen with the booster dose.
Croatian: Nije opaženo dosljedno povećanje lokalnih ili sistemskih reakcija kod ponovljenih doza tijekom primarne serije ili kod docjepljivanja, osim što je kod primjene doze docjepljivanja primijećena povećana stopa prolazne osjetljivosti na dodir (36,5 %) i osjetljivosti koja je ometala pokretanje ekstremiteta (18,5 %).
English: A higher rate of local reactions has been observed in children older than 24 months of age compared with infants (see section 4.8).
Croatian: Opažena je veća stopa lokalnih reakcija u djece starije od 24 mjeseca u usporedbi s dojenčadi (vidjeti dio 4.8).
English: Prevenar has also been shown to elicit functional antibodies (measured by opsonophagocytosis) to all vaccine serotypes following the primary series.
Croatian: Također se pokazalo da Prevenar izaziva stvaranje funkcionalnih protutijela (mjerena opsonofagocitozom) na sve serotipove cjepiva nakon primarne serije.
English: Children below 2 years old should receive the appropriate-for-age Prevenar vaccination series (see section 4.2).
Croatian: Djeca mlađa od 2 godine trebaju primiti odgovarajuću seriju cjepiva Prevenar za njihovu dob (vidjeti dio 4.2).
English: The vaccine should be given by intramuscular injection.
Croatian: Cjepivo treba dati intramuskularnom injekcijom.
English: Alternatively, when Prevenar is given as part of a routine infant immunisation programme, a two-dose schedule may be considered.
Croatian: Alternativno, kad se Prevenar daje u sklopu rutinskog programa imunizacije dojenčadi, u obzir dolazi i raspored s dvije doze.
English: These reactions were mostly moderate (less than or equal to 39 °C) and transient (see section 4.8).
Croatian: Te su reakcije većinom bile umjereno teške (manje ili jednake 39 °C) i prolazne (vidjeti dio 4.8).
English: • Vomiting, diarrhoea, decreased appetite
Croatian: • povraćanje, proljev, oslabljeni apetit
English: Also contains sodium chloride and water for injections.
Croatian: Također sadrži natrijev klorid i vodu za injekcije.
English: Children below 2 years old (including those at high-risk) should receive the appropriate-for-age Prevenar vaccination series.
Croatian: Djeca u dobi ispod 2 godine (uključujući one s visokim rizikom) trebaju primiti seriju cijepljenja Prevenarom koja odgovara njihovoj dobi.
English: When Prevenar is co-administered with hexavalent vaccines (DTaP/Hib(PRP-T)/IPV/HepB), fever ≥ 38 °C per dose was reported in 28.3 % to 48.3 % of infants in the group receiving Prevenar and the hexavalent vaccine at the same time as compared to 15.6 % to 23.4 % in the group receiving the hexavalent vaccine alone.
Croatian: Kad se Prevenar primjenjivao istovremeno s heksavalentnim cjepivima (DTaP/Hib(PRP-T)/IPV/HepB), vrućica od ≥ 38°C po dozi bila je zabilježena u 28,3% do 48,3% dojenčadi u skupini koja je primala Prevenar i heksavalentno cjepivo u isto vrijeme u usporedbi s 15,6% do 23,4% u skupini koja je primala samo heksavalentno cjepivo.
English: Detailed information on this product is available on the website of the European Medicines Agency
Croatian: Podrobnije informacije o ovom lijeku dostupne su na web stranicama Europske agencije za lijekove
English: SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF
Croatian: POSEBNO UPOZORENJE DA LIJEK TREBA ČUVATI IZVAN DOHVATA I POGLEDA
English: In Quebec, Canada Prevenar was introduced at 2, 4 and 12 months of age with a single dose catch-up programme in children up to 5 years of age.
Croatian: U Quebecu u Kanadi, Prevenar je uveden u dobi od 2, 4 i 12 mjeseca u sklopu programa nadoknade jednokratnom dozom u djece u dobi do 5 godina.
English: Whenever recommended, children at risk who are ≥ 24 months of age and already primed with Prevenar should receive 23-valent pneumococcal polysaccharide vaccine.
Croatian: Kadgod je to preporučeno, rizična djeca u dobi od 24 ili više mjeseci koja su već primala Prevenar trebaju primiti 23-valentno pneumokokno polisaharidno cjepivo.
English: Although some antibody response to diphtheria toxoid may occur, immunisation with this vaccine does not substitute for routine diphtheria immunisation.
Croatian: Iako može nastupiti djelomičan odgovor protutijela na toksoid difterije, imunizacija ovim cjepivom nije zamjena za rutinsku imunizaciju protiv difterije.
English: The potential risk of apnoea and the need for respiratory monitoring for 48-72h should be considered when administering the primary immunisation series to very premature infants (born  28 weeks of gestation) and particularly for those with a previous history of respiratory immaturity.
Croatian: Potrebno je uzeti u obzir mogući rizik od apneje i potrebu za nadzorom disanja tijekom 48 do 72 sata nakon primjene primarne serije imunizacije u nedonoščadi koja su bila vrlo rano rođena (rođeni  28 tjedana gestacije) te osobito u one koja je rođena s nezrelim dišnim sustavom.
English: Prevenar is for intramuscular use only.
Croatian: Prevenar je namijenjen samo za intramuskularnu primjenu.
English: 1 vial with syringe and 2 needles (1 for withdrawal, 1 for injection).
Croatian: 1 bočica sa štrcaljkom i 2 igle (1 za izvlačenje, 1 za injekciju).
English: Pack sizes of 1 and 10 with or without needle.
Croatian: Veličine pakovanja od 1 i 10 sa ili bez igle.
English: In general, adverse reactions reported with overdose have also been reported with recommended single doses of Prevenar.
Croatian: Općenito su nuspojave zabilježene uz predoziranje bile zabilježene i uz preporučene jednokratne doze Prevenara.
English: Fever of greater than 39.5 °C per dose was observed in 0.6 to 2.8 % of infants receiving Prevenar and hexavalent vaccines (see section 4.4).
Croatian: Vrućica viša od 39,5°C po dozi bila je opažena u 0,6% do 2,8% dojenčadi koja je primala Prevenar i heksavalentna cjepiva (vidjeti dio 4.4).
English: Therefore, in view of available data the PRAC considered that changes to the conditions of the marketing
Croatian: Stoga uzimajući u obzir dostupne podatke, PRAC smatra da su izmjene uvjeta odobrenja za stavljanje lijeka u promet opravdane.
English: Hypersensitivity to the active substances or to any of the excipients, or to diphtheria toxoid.
Croatian: Preosjetljivost na djelatne tvari ili neku od pomoćnih tvari ili na toksoid difterije.
English: Vaccination in high-risk groups should be considered on an individual basis.
Croatian: Cijepljenje visokorizičnih skupina treba razmotriti zasebno u svakom pojedinom slučaju.
English: Antibody concentrations were similar to those achieved following a three-dose infant series and a booster dose at less than 2 years of age.
Croatian: Koncentracije protutijela bile su slične onima koje su se postigle nakon serije od tri doze u dojenčadi i doze za docjepljivanje u dobi manjoj od 2 godine.
English: A significant increase was seen in the concentrations of antibodies against the seven serotypes after the polysaccharide vaccination, suggesting that immunological memory was well established.
Croatian: Značajno povećanje primijećeno je u koncentraciji protutijela na sedam serotipova nakon cijepljenja polisaharidnim cjepivom, što pokazuje da je imunološko pamćenje bilo dobro uspostavljeno.
English: Vaccine effectiveness against IPD caused by vaccine serotypes was evaluated in 3- to 59-month old children within the first four years of the implementation of the programme.
Croatian: Učinkovitost cjepiva protiv invazivne pneumokokne bolesti prouzročene serotipovima cjepiva procijenila se u djece u dobi od 3 do 59 mjeseci u prve četiri godine od uvođenja programa.
English: Fever of > 39 °C was reported in 3.3 % of children compared to 1.2 % in the control group.
Croatian: Vrućica viša od 39°C bila je zabilježena u 3,3% djece u usporedbi s 1,2% u kontrolnoj skupini.
English: The interval between the pneumococcal conjugate vaccine (Prevenar) and the 23valent pneumococcal polysaccharide vaccine should not be less than 8 weeks.
Croatian: Vremenski razmak između pneumokoknog konjugiranog cjepiva (Prevenar) i 23-valentnog pneumokoknog polisaharidnog cjepiva ne smije biti manji od 8 tjedana.
English: Theoretically, Prevenar could prevent about 6080% of serotypes causing pneumococcal AOM.
Croatian: Teoretski, Prevenar bi mogao spriječiti oko 60-80% serotipova koji uzrokuju pneumokoknu akutnu upalu srednjeg uha.
English: In the Kaiser Permanente trial, efficacy was 87.5 % (95 % CI: 7, 99) against bacteraemic pneumonia due to vaccine serotypes of S. pneumoniae.
Croatian: U ispitivanju Kaiser Permanente, djelotvornost je iznosila 87,5% (95 % CI: 7, 99) protiv bakterijske upale pluća izazvane serotipovima S. pneumoniae sadržanima u cjepivu.
English: Important information about some of the ingredients of Prevenar: This medicinal product contains less than 1 mmol sodium (23mg) per dose, i.e. essentially sodium-free.
Croatian: Važne informacije o nekim sastojcima Prevenara: Ovaj lijek sadrži natrij, manje od 1 mmola (23 mg) po jednoj dozi, u osnovi ne sadrži natrij.
English: Active immunisation against disease caused by Streptococcus pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F and 23F (including sepsis, meningitis, pneumonia, bacteraemia and acute otitis media) in infants and children from 2 months up to 5 years of age (see sections 4.2, 4.4 and 5.1).
Croatian: Aktivna imunizacija protiv bolesti uzrokovanih serotipovima 4, 6B, 9V, 14, 18C, 19F i 23F bakterije Streptococcus pneumoniae (uključujući sepsu, meningitis, pneumoniju, bakterijemiju i akutnu upalu srednjeg uha) u dojenčadi i djece u dobi od 2 mjeseca do 5 godina (vidjeti dijelove 4.2, 4.4 i 5.1).
English: • A fourth injection (booster) will be given between 11 and 15 months of age
Croatian: • Četvrta doza (docjepljivanje) daje se u dobi između 11 i 15 mjeseci.
English: In babies born very prematurely (at or before 28 weeks of gestation) longer gaps than normal between breaths may occur for 2-3 days after vaccination.
Croatian: U nedonoščadi rođenih znatno prije termina (u ili prije 28. tjedna gestacije) tijekom 2-3 dana nakon cijepljenja mogu nastati dulje stanke između udaha no obično.
English: The expiry date refers to the last
Croatian: Rok valjanosti odnosi se na zadnji dan navedenog mjeseca.
English: • Erythema multiforme (a rash causing itchy red blotches)
Croatian: • multiformni eritem (osip s crvenim mrljama koje svrbe)
English: The immune response to routine paediatric vaccines co-administered with Prevenar at different injection sites was assessed in 7 controlled clinical studies.
Croatian: Imunološki odgovor na rutinski primjenjivana pedijatrijska cjepiva koja se daju istovremeno s Prevenarom, ali se ubrizgavaju na različita mjesta, procijenio se u 7 kontroliranih kliničkih ispitivanja.
English: More than 37,816 infants were immunised with either Prevenar or a control vaccine (meningococcal conjugate group C vaccine), at 2, 4, 6 and 12-15 months of age.
Croatian: Više od 37 816 dojenčadi bilo je imunizirano pomoću Prevenara ili kontrolnog cjepiva (konjugirano cjepivo protiv meningokoka skupine C) u dobi od 2, 4, 6 i 12-15 mjeseci.
English: Prevenar will only protect against ear infections caused by the types of Streptococcus pneumoniae for which the vaccine has been developed.
Croatian: Prevenar će pružiti zaštitu samo protiv upala uha koje uzrokuju vrste bakterije Streptococcus pneumoniae za koje je cjepivo napravljeno.
English: Scientific conclusions and grounds for variation to the terms of the marketing authorisations
Croatian: Znanstveni zaključci i razlozi za izmjenu uvjeta odobrenja za stavljanje lijeka u promet
English: The vaccine should be well shaken to obtain a homogeneous white suspension and be inspected visually for any particulate matter and/or variation of physical aspect prior to administration.
Croatian: Cjepivo prije primjene treba dobro protresti da bi se dobila homogena bijela suspenzija i mora ga se vizualno pregledati da ne sadrži čestice i/ili da nema promjene u fizičkom izgledu.
English: As many pathogens other than pneumococcal serotypes represented in the vaccine may contribute to the burden of pneumonia in children, protection against all clinical pneumonia is expected to be lower than for invasive pneumococcal disease.
Croatian: Budući da mnogi patogeni, osim serotipova pneumokoka zastupljenih u cjepivu, mogu izazvati upalu pluća u djece, očekuje se da će zaštita protiv svih kliničkih upala pluća biti manja nego protiv invazivne pneumokokne bolesti.
English: Effectiveness (no microbiological confirmation of diagnosis was performed) against non-bacteraemic pneumonia was also assessed.
Croatian: Procijenila se i učinkovitost protiv nebakterijske upale pluća(nije provedena mikrobiološka potvrda dijagnoze).
English: Redness was reported in 40.0 % of children, and induration was reported in 32.2 % of subjects.
Croatian: Crvenilo je bilo zabilježeno u 40,0% djece, a otvrdnuće je bilo zabilježeno u 32,2% ispitanika.
English: Efficacy of Prevenar against AOM was assessed as a secondary endpoint in the Kaiser Permanente trial.
Croatian: Djelotvornost Prevenara protiv akutnih upala srednjeg uha procijenila se kao sekundarni ishod u ispitivanju Kaiser Permanente.
English: Data on concomitant administration of Prevenar with Infanrix hexa (DTaP/Hib(PRP-T)/IPV/HepB vaccine) have shown no clinically relevant interference in the antibody response to each of the individual antigens when given as a 3 dose primary vaccination.
Croatian: Podaci o istovremenoj primjeni Prevenara s cjepivom Infanrix hexa (DTaP/Hib(PRP-T)/IPV/HepB cjepivo) pokazali su da nema klinički važne interferencije između odgovora protutijela na svaki od ovih pojedinih antigena kad se daje kao primarno cijepljenje od 3 doze.
English: - for children with seizure disorders or with a prior history of febrile seizures.
Croatian: - za djecu s konvulzivnim poremećajima ili febrilnim konvulzijama u anamnezi.
English: Children aged 24 months - 5 years: one single dose.
Croatian: Djeca u dobi od 24 mjeseca do 5 godina: jedna jednokratna doza.
English: Adverse reactions reported in clinical trials or from the post-marketing experience are listed in the following table per system organ class and per frequency and this is for all age groups.
Croatian: Nuspojave zabilježene u kliničkim ispitivanjima ili razdoblju nakon stavljanja lijeka u promet navedene su u sljedećoj tablici prema klasifikaciji organskih sustava i učestalosti za sve dobne skupine:
English: The preferred sites are anterolateral aspect of the thigh (vastus lateralis muscle) in infants or the deltoid muscle of the upper arm in young children.
Croatian: Za mjesto primjene, prednost se daje anterolateralnoj strani natkoljenice (musculus vastus lateralis) u dojenčadi ili deltoidni mišić na nadlaktici u male djece.
English: Pack size of 1 vial with syringe and 2 needles (1 for withdrawal, 1 for injection).
Croatian: Veličine pakovanja od 1 bočice sa štrcaljkom i 2 igle (1 za izvlačenje, 1 za injekciju).
English: In a clinical trial that compared separate with concomitant administrations of Prevenar (three doses at 2, 3.5, 6 months and a booster dose at approximately 12 months) and Meningitec (meningococcal C conjugate vaccine; two doses at 2 and 6 months and a booster dose at approximately 12 months) there was no evidence of immune interference between the two conjugate vaccines after the primary series or after
Croatian: U kliničkom ispitivanju koje je uspoređivalo zasebnu i istovremenu primjenu Prevenara (tri doze u 2., 3,5. i 6. mjesecu i docjepljivanje u približno 12. mjesecu) i Meningiteca (meningokokno C konjugirano cjepivo; dvije doze u 2. i 6. mjesecu i doza za docjepljivanje u približno 12. mjesecu) nije bilo dokaza imunološke interferencije između ova dva konjugirana cjepiva nakon primjene primarne serije ili doze za
English: Preliminary data from England and Wales reported less than 1 year following introduction of routine immunisation at 2, 4 and 13 months with a single dose catch-up programme for children 13 to 23 months of age have suggested that effectiveness of this schedule might be lower against serotype 6B than against
Croatian: Preliminarni podaci iz Engleske i Walesa zabilježeni manje od 1 godine nakon uvođenja rutinske imunizacije u dobi od 2, 4 i 13 mjeseci s programom nadoknade jednokratnom dozom za djecu u dobi od 13 do 23 mjeseca pokazuju da bi učinkovitost ovog rasporeda mogla biti slabija protiv serotipa 6B nego protiv drugih serotipova cjepiva.
English: However, antibody responses to booster doses in toddlers following two-dose or three-dose infant series were comparable for all 7 vaccine serotypes and indicated that both infant regimens had elicited adequate priming.
Croatian: Međutim, odgovori protutijela na dozu docjepljivanja u male djece nakon serije od dvije ili tri doze u dojenčadi bili su slični za svih 7 serotipova cjepiva i ukazivali su na to da oba rasporeda cijepljenja dojenčadi izazivaju odgovarajuću primarnu reakciju.
English: As with any vaccine, Prevenar may not protect all individuals receiving the vaccine from pneumococcal disease.
Croatian: Kao i svako drugo cjepivo, Prevenar ne mora zaštititi sve pojedince koji prime ovog cjepivo od pneumokokne bolesti.
English: The immunogenicity of a two-dose primary series in infants plus a booster at about one year of age has been documented in several studies.
Croatian: Imunogenost primarne serije od dvije doze u dojenčadi uz dozu docjepljivanja u dobi od približno godinu dana zabilježena je u nekoliko ispitivanja.
English: Significant increases in antibody (measured by ELISA) to all vaccine serotypes were seen after administration of single doses of Prevenar to children aged 2 to 5 years.
Croatian: Značajno povišena protutijela (mjereno ELISA-om) na sve serotipove cjepiva opažena su nakon primjene jednokratnih doza Prevenara djeci u dobi od 2 do 5 godina.
English: Do not administer Prevenar intravenously.
Croatian: Nemojte primjenjivati Prevenar intravenski.
English: Children aged 2 to 5 years should receive one injection.
Croatian: Djeca u dobi od 2 do 5 godina trebaju primiti jednu injekciju.
English: Very rare side effects (these may occur with up to 1 in 10,000 doses of the vaccine) are: • Enlarged lymph nodes or glands (lymphadenopathy) near the injection site, such as under the arm or
Croatian: Vrlo rijetke nuspojave (mogu se pojaviti u najviše 1 na 10 000 primijenjenih doza cjepiva) su: • povećani limfni čvorovi ili žlijezde (limfadenopatija) u blizini mjesta primjene injekcije, na primjer u
English: Additionally, for vaccine serotypes, protection against otitis media is expected to be substantially lower than protection against invasive disease.
Croatian: Osim toga, u pogledu serotipova cjepiva, očekuje se da će zaštita od upale srednjeg uha biti znatno niža od zaštite od invazivne bolesti.
English: A higher rate of local reactions has been observed in children older than 24 months of age compared with infants.
Croatian: Veća stopa lokalnih infekcija bila je opažena u djece starije od 24 mjeseca u usporedbi s dojenčadi.
English: In a study, including 1,662 children, fever of  38 °C was reported in 41.2 % of children who received Prevenar simultaneously with DTP as compared to 27.9 % in the control group.
Croatian: U jednom ispitivanju, koje je uključilo 1662 djece, zabilježena je vrućica od  38°C u 41,2% djece koja su primila Prevenar istovremeno s DTP-om u usporedbi s 27,9% u kontrolnoj skupini.
English: Limited data have demonstrated that Prevenar (three dose primary series) induces an acceptable immune response in infants with sickle cell disease with a safety profile similar to that observed in non-high-risk groups (see section 5.1).
Croatian: Ograničeni podaci pokazuju da Prevenar (primarna serija od tri doze) izaziva prihvatljiv imunološki odgovor u dojenčadi s anemijom srpastih stanica, uz sigurnosni profil koji je sličan onome opaženom u skupina u kojih nema visokog rizika (vidjeti dio 5.1).
English: Prevenar is a pneumococcal vaccine.
Croatian: Prevenar je pneumokokno cjepivo.
English: Efficacy of Prevenar against acute otitis media (AOM) was assessed in a randomised, double blind, clinical trial of 1,662 Finnish infants immunised with either Prevenar or a control vaccine (Hepatitis B vaccine), at 2, 4, 6 and 12-15 months of age.
Croatian: Djelotvornost Prevenara protiv akutne upale srednjeg uha procijenila se u randomiziranom, dvostruko slijepom kliničkom ispitivanju u 1662 dojenčadi u Finskoj koja su bila imunizirana pomoću Prevenara ili kontrolnog cjepiva (cjepivo protiv hepatitisa B) u dobi od 2, 4, 6 i 12-15 mjeseci.
English: In the USA, generalised vaccination with Prevenar using a four-dose series in infants and a catch-up programme for children up to 5 years of age was introduced in 2000.
Croatian: Sjedinjenim Američkim Državama je 2000. godine uvedeno generalizirano cijepljenje Prevenarom u seriji od četiri doze u dojenčadi i program nadoknade cijepljenja u djece u dobi do 5 godina.
English: Please speak to your doctor, pharmacist, or nurse for more information.
Croatian: Obratite se svom liječniku, ljekarniku ili medicinskoj sestri za dodatne informacije.